化合物 Zotiraciclib HCl T70897

Product Introduction
Bioactivity


英文名: Zotiraciclib HCl

描述: Zotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: 4SC-101 | IMU838 | SC-12267 | IMU-838 | Zotiraciclib HCl | IM-90838 | Vidofludimus | IM90838 | IMU 838 | 4SC101 | SC12267 | SC 12267 | 4SC 101 | IM 90838

化合物 Zotiraciclib HCl T70897信息由TargetMol中国为您提供，如您想了解更多关于化合物 Zotiraciclib HCl T70897报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途